Novartis reports positive results for Aimovig in phase 2 episodic migraine trial

pharmanewsdaily- October 4, 2020 0

Novartis said that a five-year phase 2 clinical trial of migraine prevention drug Aimovig (erenumab-aooe) has delivered strong long-term safety and efficacy results in patients ... Read More

Nestlé to fully own Aimmune Therapeutics through $2bn deal

pharmanewsdaily- September 1, 2020 0

Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in ... Read More

Novartis bags Kesimpta FDA approval for relapsing forms of MS

pharmanewsdaily- August 21, 2020 0

Kesimpta FDA approval for RMS: Novartis has bagged approval from the US Food and Drug Administration (FDA) for its blood cancer drug Kesimpta (ofatumumab, formerly OMB157) ... Read More

Northway Biotechpharma to manufacture Memo’s Covid1-9 drug MTX-COVAB

pharmanewsdaily- August 15, 2020 0

Memo Therapeutics (MTx), a Swiss biotech company, has entered into a partnership with Northway Biotechpharma, under which the latter will manufacture the former's MTX-COVAB - ... Read More

UCB signs $2bn worth deal with Roche for AD drug candidate UCB0107

pharmanewsdaily- July 29, 2020 0

Belgian pharma company UCB has signed a global exclusive license deal worth up to $2 billion for its Alzheimer's Disease drug candidate (AD drug candidate) ... Read More

Nestlé Nespresso to expand Romont production center with $170m investment

pallavi123- July 10, 2020 0

Nestlé Nespresso (Nespresso) will invest CHF160 million ($170.28 million) to expand its Romont production center in Switzerland to address the growing consumer demand for its ... Read More

Barry Callebaut wraps up acquisition of GKC Foods (Australia)

pallavi123- July 3, 2020 0

Barry Callebaut acquisition of GKC Foods : Switzerland-based Barry Callebaut Group has wrapped up its previously announced acquisition of GKC Foods (Australia), a producer of ... Read More

Roche acquires DNA sequencing technology company Stratos Genomics

pharmanewsdaily- May 24, 2020 0

Roche acquisition of Stratos Genomics : Swiss pharma giant Roche has acquired US-based early-stage DNA sequencing technology company Stratos Genomics for an undisclosed price. The ... Read More

Construction begins on Merck Biotech Development Center in Switzerland

pharmanewsdaily- January 29, 2020 0

Merck has broken ground on the €250 million Merck Biotech Development Center, a new biotech development facility in Switzerland at Corsier-sur-Vevey. The new facility will ... Read More

ForaCare Suisse launches FOR A 6 GTel diabetes monitoring device

pharmanewsdaily- January 4, 2020 0

ForaCare Suisse has launched a new cellular multi-functional diabetes monitoring device FORA 6 GTel based on its Lab in the Pocket technology. The Lab in ... Read More